Healthcare private equity has shown remarkable resilience since the emergence of Covid-19 in 2020. Although the industry was acutely affected by the pandemic and experienced some initial contraction, 2021 saw record private equity investments and other M&A activity as firms look to position themselves on the right side of change in the industry.
Investments in new technologies and delivery models, especially digital health, are growing to meet evolving patient demands; smaller providers are partnering with larger practices to mitigate financial and operational vulnerabilities; and the power of technology is being harnessed to drive efficiencies that are resulting in ever higher valuations.
Our report takes a close look at the record year that was, and what we should expect to see as we look ahead.
